Study of individualized homoeopathic medicine for rheumatoid arthritis

Effectiveness of individualized homoeopathic medicine in treatment of rheumatoid arthritis - A Quasi experimental study - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/07/090657

Enrollment

Registered

2025-07-10

Start date

Unknown

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M048- Other autoinflammatory syndromes

Interventions

Intervention1: Individualized homeopathic medicine: After enrollment the case will be repertorised.Appropriate potentized Individualised Homoeopathic Medicine will be administered in minimum dose in

Eligibility

Inclusion criteria

Inclusion criteria: 20-70years both males and females ,Patients presenting with symmetrical polyarthritis , Anti-CCP antibodies greater than 20IU/mL

Exclusion criteria

Exclusion criteria: Patients with other severe systemic illness ,Pregnant women, lactating mothers, Immunocompromised patients

Design outcomes

Primary

Measure	Time frame
To evaluate the effectiveness of individualized homoeopathic medication in reducing the disease activity in rheumatoid arthritis measured by simplified Disease Activity Index(SDAI).Timepoint: Baseline,3rd month,6th month,9th month,12th month	—

Secondary

Measure	Time frame
To assess the effectiveness of homoeopathic medicine in reducing the levels of anti-CCP in rheumatoid arthritis.Timepoint: Baseline,6th month and end of study	—

Countries

India

Contacts

Public ContactDrR Sitharthan

National Homoeopathic Research Institute in Mental Health, kurichy, kottayam

sitharthan.r@gmail.com9443203174

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026